Table 2.
Patient factors, management, and outcomes.
| Variable | Total (%) |
|---|---|
| Total cases | 100 (n = 58) |
| Mean age (years) | 68.0 |
| Gender | |
| Male | 71.4 |
| Female | 27.6 |
| Underlying Condition | |
| Diabetes mellitus | 94.7 |
| History of cancer | 4.9 |
| History of transplant | 3.5 |
| Microbiology | |
| Pseudomonas spp. | 64.3 |
| Aspergillus spp. | 16.1 |
| S. aureus | 12.5 |
| Candida spp. | 12.5 |
| Culture negative | 8.9 |
| CN Involvement | |
| CN VII | 55.2 (n = 32) |
| CN function recovery | 72.0 |
| Disease cure rate | 87.5 |
| Survival | 93.8 |
| Multiple CN involvement | 25.9 |
| Surgery or Procedure | 50.0 |
| Overall outcomes | |
| Disease cure rate | 91.4 |
| Survival | 91.4 |
| All-cause mortality | 8.6 |
CN: cranial nerve; HBOT: hyperbaric oxygen therapy.
Surgical management includes extensive debridement.
Mastoidectomy, or facial nerve decompression.
Procedure includes local external auditory canal debridement.